Riskpilot← Back to searchSign inGet full accessVetaDerm Göteborg AB
ABActiveOrg 5592370885Kabelgatan 2Veterinary activities · NACE 7500Est. 20204 employees
Revenue 2024
SEK 6,4M
+16% vs 2023
EBITDA margin
1.1%
-56% vs 2023
Equity ratio
14.3%
Financial strength
Net profit 2024
SEK 9K
-92% vs 2023
| Revenue | SEK 6,4M | +16% |
| EBITDA | SEK 68K | -56% |
| Net profit | SEK 9K | -92% |
| Total assets | SEK 1,4M | +2% |
| Equity | SEK 207K | +5% |
| Employees | 4 | — |
Legal name
VetaDerm Göteborg AB
Org number
5592370885
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
16 januari 2020
Share capital
SEK 25 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall direkt eller indirekt, bedriva djurvård, utöva försäljning av djurvårdsprodukter och forsknings- och utvecklingsarbeten inom medicin- och veterinärmedicin samt äga och förvalta fast och lös egendom och därmed förenlig verksamhet.
Address
Kabelgatan 2
Email
robert@vetaderm.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 090 | 2 409 | 4 347 | 5 523 | 6 399 |
| Staff expenses | — | — | −2 406 | — | — |
| EBITDA | −293 | −275 | 92 | 154 | 68 |
| Depreciation & amort. | −0 | −19 | −38 | −49 | −59 |
| EBIT | −293 | −294 | 54 | 105 | 9 |
| Net financials | — | — | −2 | 3 | — |
| Profit before tax | −293 | −294 | 52 | 108 | 9 |
| Tax | −0 | −0 | — | −0 | −0 |
| Net profit | −293 | −294 | 52 | 108 | 9 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 198 | 1 646 | 1 459 | 1 423 | 1 446 |
| Equity | 32 | 37 | 89 | 197 | 207 |
| Long-term debt | 0 | 0 | — | 0 | 0 |
| Short-term debt | 1 167 | 1 608 | 1 370 | 1 226 | 1 239 |
| Total debt | 1 167 | 1 608 | 1 370 | 1 226 | 1 239 |
EBITDA margin
1.1%
This company
15.8%
Market median
-93% vs market
20202024
Equity ratio
14.3%
This company
38.2%
Market median
-63% vs market
20202024
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
20202024
Net profit margin
0.1%
This company
8.1%
Market median
-99% vs market
20202024
Asset turnover
4.43×
This company
1.12×
Market median
+296% vs market
20202024
Debt / equity
5.99×
This company
0.62×
Market median
-866% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EA Chief Auditor | Chief Auditor | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Contrigio Holding AB
VetaDerm Göteborg AB Board members of VetaDerm Göteborg AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eric Anton Snickert | Chief Auditor | 0 companies |
| Jens Bertil Åhman | Deputy Board Member | 0 companies |
| Robert Daniel Cikota | Chairman | 0 companies |
| Maj Susanne Elisabeth Åhman | Board of Directors | 0 companies |